← All organizations

Albert B. Sabin Vaccine Institute

Academic/HospitalWebsite ↗

Also known as: Albert B. Sabin Vaccine Institute | The Albert B. Sabin Vaccine Institute

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 26, 2025

Timeline

1990s

Jan 1, 1993
Albert B. Sabin Vaccine Institute— Founded

Drugs by trial phase (13 distinct, 13 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (19)

NCT06803342Lead sponsorPhase 2Jun 26, 2025
NCT06620003OfficialPhase 2Jan 31, 2025
NCT06620003Lead sponsorPhase 2Jan 31, 2025
NCT06036602Lead sponsorPhase 2Feb 29, 2024
NCT05817422Study chairPhase 2Sep 25, 2023
NCT05817422Lead sponsorPhase 2Sep 25, 2023
NCT05343871Lead sponsorPhase 4Jul 5, 2022
NCT04723602Lead sponsorPhase 1Jan 6, 2021
NCT04723602Study chairPhase 1Jan 6, 2021
NCT01385189Lead sponsorPhase 1May 1, 2012
NCT01385189Study directorPhase 1May 1, 2012
NCT01261130Overall official - principal investigatorPhase 1Nov 1, 2011
NCT01308268CollaboratorN/ADec 1, 2010
NCT00939198Overall official - principal investigatorN/AAug 1, 2009
NCT00939198Lead sponsorN/AAug 1, 2009

Details

Founded: Washington D.C., US Jan 1, 1993
Last known activity: Jun 26, 2025